Paul M. Seldon

546 total citations
9 papers, 455 citations indexed

About

Paul M. Seldon is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Paul M. Seldon has authored 9 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Physiology and 4 papers in Immunology. Recurrent topics in Paul M. Seldon's work include Asthma and respiratory diseases (4 papers), Phosphodiesterase function and regulation (3 papers) and Mast cells and histamine (2 papers). Paul M. Seldon is often cited by papers focused on Asthma and respiratory diseases (4 papers), Phosphodiesterase function and regulation (3 papers) and Mast cells and histamine (2 papers). Paul M. Seldon collaborates with scholars based in United Kingdom, United States and Canada. Paul M. Seldon's co-authors include Peter J. Barnes, Mark A. Giembycz, Koremu Meja, M A Giembycz, Jane A. Mitchell, Magdi H. Yacoub, Michael A. Saunders, Maria G. Belvisi, A.C. Chu and E.D. Seaton and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, British Journal of Pharmacology and Molecular Pharmacology.

In The Last Decade

Paul M. Seldon

9 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul M. Seldon United Kingdom 9 180 153 151 86 76 9 455
Suetsugu Mue Japan 15 151 0.8× 200 1.3× 246 1.6× 56 0.7× 12 0.2× 56 569
Mary Carol Conroy United States 13 163 0.9× 138 0.9× 222 1.5× 31 0.4× 27 0.4× 20 514
Danielle Joseph France 12 249 1.4× 110 0.7× 143 0.9× 99 1.2× 16 0.2× 20 451
Neil Gozzard United Kingdom 13 231 1.3× 153 1.0× 128 0.8× 154 1.8× 14 0.2× 23 448
Clayton S. Spada Ireland 12 275 1.5× 81 0.5× 141 0.9× 100 1.2× 46 0.6× 25 546
Monica Malhotra United States 7 68 0.4× 157 1.0× 116 0.8× 18 0.2× 41 0.5× 9 406
Frank R. Wettey United Kingdom 6 170 0.9× 138 0.9× 114 0.8× 45 0.5× 15 0.2× 9 386
Sung Gil Ha United States 16 189 1.1× 353 2.3× 259 1.7× 71 0.8× 11 0.1× 21 670
Elizabeth Townsend United Kingdom 5 217 1.2× 122 0.8× 131 0.9× 58 0.7× 22 0.3× 7 398
Anick Langlois Canada 11 173 1.0× 98 0.6× 161 1.1× 72 0.8× 15 0.2× 15 382

Countries citing papers authored by Paul M. Seldon

Since Specialization
Citations

This map shows the geographic impact of Paul M. Seldon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul M. Seldon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul M. Seldon more than expected).

Fields of papers citing papers by Paul M. Seldon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul M. Seldon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul M. Seldon. The network helps show where Paul M. Seldon may publish in the future.

Co-authorship network of co-authors of Paul M. Seldon

This figure shows the co-authorship network connecting the top 25 collaborators of Paul M. Seldon. A scholar is included among the top collaborators of Paul M. Seldon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul M. Seldon. Paul M. Seldon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Seaton, E.D., et al.. (2006). Investigation of the mechanism of action of nonablative pulsed-dye laser therapy in photorejuvenation and inflammatory acne vulgaris. British Journal of Dermatology. 155(4). 748–755. 72 indexed citations
2.
Seldon, Paul M., Koremu Meja, & Mark A. Giembycz. (2005). Rolipram, salbutamol and prostaglandin E2 suppress TNFα release from human monocytes by activating Type II cAMP-dependent protein kinase. Pulmonary Pharmacology & Therapeutics. 18(4). 277–284. 13 indexed citations
3.
Seldon, Paul M. & Mark A. Giembycz. (2001). Suppression of granulocyte/macrophage colony‐stimulating factor release from human monocytes by cyclic AMP‐elevating drugs: role of interleukin‐10. British Journal of Pharmacology. 134(1). 58–67. 16 indexed citations
4.
Meja, Koremu, Paul M. Seldon, Yasuyuki Nasuhara, et al.. (2000). p38 MAP kinase and MKK‐1 co‐operate in the generation of GM‐CSF from LPS‐stimulated human monocytes by an NF‐κB‐independent mechanism. British Journal of Pharmacology. 131(6). 1143–1153. 63 indexed citations
5.
Seldon, Paul M., David A. Stevens, Ian M. Adcock, et al.. (1998). Albuterol Does Not Antagonize the Inhibitory Effect of Dexamethasone on Monocyte Cytokine Release. American Journal of Respiratory and Critical Care Medicine. 157(3). 803–809. 15 indexed citations
6.
7.
Saunders, Michael A., Jane A. Mitchell, Paul M. Seldon, et al.. (1997). Release of granulocyte‐macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. British Journal of Pharmacology. 120(4). 545–546. 100 indexed citations
8.
Seldon, Paul M., Peter J. Barnes, Koremu Meja, & M A Giembycz. (1995). Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.. Molecular Pharmacology. 48(4). 747–757. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026